Smart Science.
Better Ingredients.
Bio-Intelligence as a Service
Predictive Testing for Smarter Ingredient Validation
NemaLife is shaping the future of ingredient innovation with its AI-powered in vivo screening platform that uses Nobel-prize backed micro-organism C. elegans. Our
proprietary platforms deliver predictive data on efficacy and safety without the need for mammalian testing.
Combination
Ingredient Solutions
Next-Gen Health & Well-Being , Proven in Vivo.
Lorem Ipsum Lorem Ipsum
Lorem Ipsum Lorem Ipsum
Lorem Ipsum Lorem Ipsum Lorem Ipsum Lorem Ipsum Lorem Ipsum Lorem Ipsum Lorem Ipsum Lorem Ipsum
Lorem Ipsum Lorem Ipsum Lorem Ipsum Lorem Ipsum Lorem Ipsum Lorem Ipsum Lorem Ipsum Lorem Ipsum
Scientific Foundations
The organism, conserved biology, peer-reviewed proof.
Nobel Prize recognized C.elegans discoveries underpin our model
Genes in C. elegans similar to humans indicating strong conserved biology
Published bioactive ingredients that show efficacy in C. elegans also improve human health outcome
publications on C. elegans by the NemaLife team
Bio-Intelligence Ingredient Innovation
Faster results, AI-driven, health-benefit validated
Discovery programs on multiple ingredient categories ranging from biotics to botanicals
New claim signals unlocked for partners
consumer products on the market informed by our data
Partner patents enabled
Clinical trials initiated by partners
Explore Our Latest Insights
NemaLife Unveils BioSēq™ to Decode Bioactive Mechanisms and Fast-Track Ingredient Innovation
NemaLife launches BioSēq™, transcriptomics-powered engine to decode bioactive mechanisms to.....
Probiotics and Gut Colonization - A Deep Dive into Feeding Mechanics Using C. elegans
Introduction Probiotics—live bacteria known for their health benefits—are becoming a popular supplement to.....
A Nobel Prize Winning Model: Significance for Human Health and Bioactive Discovery
The Nobel Prize in Physiology or Medicine has honored some of the most transformative scientific....